Characterizing new users of NSAIDs before and after rofecoxib withdrawal (Q36388021)

13 August 2017

Characterizing new users of NSAIDs before and after rofecoxib withdrawal (English)

1 reference

13 August 2017

Cara Usher

1

1 reference

13 August 2017

Kathleen Bennett

series ordinal

2

1 reference

13 August 2017

Mary Teeling

series ordinal

3

1 reference

13 August 2017

John Feely

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

19 October 2006

1 reference

British Journal of Clinical Pharmacology

13 August 2017

1 reference

13 August 2017

63

1 reference

13 August 2017

4

1 reference

13 August 2017

494-497

1 reference

Prescriptions for chronic high-dose cyclooxygenase-2 inhibitors are often inappropriate and potentially dangerous

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Risk of cardiovascular events associated with selective COX-2 inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203243

Pharmacoepidemiology--an Irish perspective

30 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17054665

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2006.02784.X

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

17054665

1 reference